Overview
- Guangzhou Medical University surgeons led by Jianxing He implanted a gene-edited Bama Xiang pig’s left lung into a 39-year-old man on May 15, 2024.
- The graft showed no hyperacute rejection or infection initially, then developed severe pulmonary edema at 24 hours and antibody-mediated injury on days three and six, with partial recovery by day nine.
- Observation ended at 216 hours at the family’s request, and the native right lung remained in place, limiting assessment of standalone function.
- The donor pig, developed with Clonorgan Biotechnology, carried six edits (GTKO, B4GalNT2KO, CMAHKO, CD55, CD46, TBM) and the protocol used intensive multi-drug immunosuppression.
- Researchers and outside experts say key hurdles include immune rejection, infection risk, organ preservation, and the need for more controlled studies before attempts in living patients.